Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
COMPASS Pathways Granted Patent Covering Use of Its Psilocybin ...
Compass Pathways Patents – Key Insights and Stats - Insights;Gate
CMPS | Обзор IPO COMPASS Pathways | Анализ IPO CMPS
Compass Pathways Touts Phase 3 COMP360 Depression Data, Eyes Rolling ...
COMPASS Pathways Is Trying to Patent Psilocybin for More Mental Health ...
Compass Pathways Streamlines Operations with Workforce Reduction and ...
Compass Pathways Granted Its Tenth Overall Patent Related To Psilocybin ...
Compass Pathways COMP360: 2026 Training Milestone & FDA Roadmap
Compass Pathways Announces Pricing of $150 Million Public Offering
COMPASS Pathways (CMPS) Stock Soars 25% on Trump's Psychedelics ...
Compass Pathways Launches Proposed $150.0 Million Public Offering ...
COMPASS Pathways Acquires Patent for Psilocybin, Which May Help with ...
Compass Pathways Stock at Rebecca Hart blog
Compass Pathways establishes research collaboration with Mindful Health ...
COMPASS Pathways logo in transparent PNG and vectorized SVG formats
Compass Pathways Psilocybin Patent Upheld | Psychedelic Spotlight
This Week in Psychedelic Stocks: Compass Pathways Wins Patent Battle ...
Compass Pathways
Pipeline overview | Compass Pathways
COMPASS Pathways Careers | Levels.fyi
London's COMPASS Pathways gets $285M funding boost to advance ...
COMPASS PATHWAYS files patent for 218 novel psychedelic drugs : r ...
Compass Pathways Stock Extends Gains on New Patent for Psilocybin ...
Compass Pathways Psilocybin Patent Upheld | Cannabis Law Report
NEW MindMed MDMA trials, Compass Pathways Patent, Small Pharma DMT ...
Compass Pathways at Kenneth Bray blog
Compass Pathways Establishes Strategic Collaboration with Radial to ...
CMPS News Today | Why did Compass Pathways stock go up today?
Compass Pathways Eyes FDA Approval for Psilocybin Depression Drug ...
COMPASS Pathways Salaries | Levels.fyi
Compass Pathways Soars on Phase 3 Psilocybin Trial Success
COMPASS Pathways plc Stock — CMPS Overview — Roic AI
Compass Pathways PLC 8-K Report: Key Announcements for January 2025 ...
Compass Pathways (Nasdaq:CMPS) Enters Strategic Collaboration with ...
Compass Pathways Successfully Achieves Primary Endpoint in Second Phase ...
Pathways Compass by Carolyn Peper on Prezi
MindMed Delays Project Lucy & Compass Pathways Has a Challenged Patent ...
Digital technologies | Compass Pathways
COMPASS Pathways plc announces financial results and business ...
Compass Pathways Pitch Deck to Raise $80m Series-B Round
Compass Pathways (NASDAQ:CMPS) Stock Price News
Compass Pathways IPO - AmeriVet Securities
Why Did COMPASS Pathways Plunge 10.03%?
Compass Pathways Launches Proposed $150.0 Million Public Offering
Compass Pathways To Start Phase II Trial For Psilocybin PTSD Therapy ...
Magic mushrooms to treat depression? COMPASS Pathways pushes forward ...
Is Compass Pathways Poised for Success? | Psychedelic Invest
Working at COMPASS Pathways | Glassdoor.co.uk
Compass Pathways Announces 2025 Financial Results and Highlights ...
Compass Career Pathways | Kodiak College | Kodiak College
As COMPASS Pathways continues its attempts to build a psychedelic ...
Compass Pathways Rises 10% After Positive Phase 3 Results for COMP360 ...
COMPASS Pathways Phase 2 Psilocybin Study
Compass Pathways – World Social Media Awards
Our work | Compass Pathways
Compass Pathways releases topline results for psilocybin in depression ...
COMPASS Pathways announces pricing of upsized initial public offering
A Look at Compass Pathways and Clinical Results : psychedelicinvest
COMPASS pathways brand generation - Projects - Like Sherbet
Free Divided Compass Pathways Image - Aerial, Symmetry, Compass ...
Compass Pathways Accelerates COMP360 TRD Launch by 9–12 Months | CMPS ...
Psychedelic Bulletin #132: COMPASS Pathways Amends Phase 3 Program ...
Compass Pathways President Steps Down To An Advisory Role | the deep dive
Buy COMPASS Pathways Stock – CMPS Stock Quote Today & Investment ...
COMPASS Pathways plc (CMPS) Stock Price, News, Quote & History - Yahoo ...
Compass Pathways Closes Enrollment For Phase IIb Psilocybin Clinical ...
#cmps | Compass Pathways
How to Buy Compass Pathways Stock [2026] | Invest in CMPS
COMPASS Pathways Announces Positive Results From Groundbreaking Phase ...
Reality Check: Reflections on Compass Pathways' Phase IIb Topline Results
Compass Pathways: New Clinical Data Release Set to Affect Stock Dynamics
Compass Pathways' Series B Pitch Deck Raised $80 Million for ...
Compass pathways, psychedelic patents and pharma: Drug reform advocacy ...
COMPASS Pathways' Psilocybin Patent Questioned By UK Patent Examiner
Comprehensive Analysis of Compass Pathways: $CMPS | Psychedelic Vantage ...
Compass Group Patents Key Insights & Stats - Insights;Gate
Compass Pathways: Forging Independent Path With Competition Nearing ...
COMPASS Pathways: Private Placement Buys Less Time Than Expected ...
COMPASS Pathways: Accelerating Patient Access To Evidence Based ...
Drafting Compass print - 1927 patent – The Patent Print Shop
Compass Pathways' Opens Trading at $23.40 – Above Expected Range ...
Compass Pathways: Will The Stock Rally Last?
Compass Pathways' Phase 2B study, the largest scale psychedelics ...
Compass Pathways: Stock Soars As Data Sets Up Psilocybin Approval Shot ...
International Intellectual Property Law Association (IIPLA) on LinkedIn ...
The Top Companies Leading Psilocybin Research & Therapy
slide13
slide12
slide4
slide26
Patents & Commercialization of Patent Assets | Patent Strategy & IP ...
CMPS Q3 2025 Earnings Report on 11/4/2025
slide20
The Psychedelic News Feed - Psychedelic Alpha
slide15
slide21
slide22
slide11
slide9
slide14
Patent Pathways® (a 501(c)(3) organization) posted on LinkedIn
slide5
slide3
